The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?
Gal Bitan
Topics & Concepts
MedicineAtrophyBioinformaticsClinical trialIntensive care medicineInternal medicineBiologyParkinson's Disease Mechanisms and TreatmentsGinkgo biloba and Cashew ApplicationsNuclear Receptors and Signaling